David Liebner

David Liebner, MD


Make an Appointment

Overall Patient Satisfaction Rating

4.9 out of 5




I am a medical oncologist with a clinical specialization in bone and soft-tissue sarcoma and a research focus in cancer bioinformatics. At The Ohio State University, I serve as an assistant professor in Medical Oncology and in Biomedical Informatics.

My current work focuses on developing computational tools to improve prognostic and predictive models in sarcoma with the aim of facilitating more personalized cancer treatments. In particular, I’m interested in integrating results from sophisticated tests on patient tumors -- including next-generation sequencing, proteomics, and metabolimics -- with clinical databases in order to help understand what treatments work best in individual patients. As part of this work, I have led the creation of a Sarcoma Registry at the OSUCCC – James to allow us to capture this clinical data in a rigorous manner.

I’m inspired by the mission of the OSUCCC – James to achieve a cancer-free world, and feel honored to be a part of that vision. Because each patient is unique, the medical and therapeutic regimens we provide should mirror that, and I believe the better our ability to accurately predict responses and customize treatments, the more positive outcomes we will see.

I’ve authored or co-authored numerous medical manuscripts on sarcoma and am active in national and international research groups that are dedicated to developing novel treatments for sarcomas. I have served as the principal investigator or co-investigator on nearly 40 clinical studies at Ohio State. I’m excited about the work we’re doing at the OSUCCC – James, and all the potential medical breakthroughs to come.

Education and Background


State University of New York at Buffalo

Buffalo, NY


SUNY at Buffalo

Buffalo, NY



Ohio State University Wexner Medical Center

Columbus, OH

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine (Subspecialty: Medicine Oncology)

Academic Department

Department of Internal Medicine

Division of Medical Oncology

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 12/20/2018, Dr. Liebner has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

Foundation Medicine


Patient Satisfaction Review

The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.

Overall Ratings (out of 130 reviews)
4.9 out of 5
Kept you informed about your condition and treatment

4.9/ 5

Amount of time spent with you

4.9/ 5

Concern for your questions and issues

4.9/ 5

Skill and knowledge

4.9/ 5

Overall quality of care

4.9/ 5

Patient Comments (8 total comments)

Reviewed: 4/27/2019

Dr. Liebner is very knowledgeable and spends a good amount of time explaining my situation and answering all my questions. I am very impressed with his expertise and the quality of care he provides

Reviewed: 4/12/2019

Dr. Liebner and his staff were/are remarkable. Very happy we are The James!

Reviewed: 3/24/2019

Dr. Liebner is amazing. He's a lifesaver in our son's case!

Reviewed: 3/15/2019

2. Always spends as much time as needed.

Reviewed: 3/8/2019

Everyone connected to The James could NOT be better!

Reviewed: 3/2/2019

Dr. Liebner is the best medical oncologist I have had in the 6 years I have been seeking treatment for my cancer/tumor.

Reviewed: 2/22/2019

Dr. Liebner - all the staff top notch!

Reviewed: 2/17/2019

This was my first meeting with Dr. Liebner. I am very confidant that he will provide the best medical treatment available to me.


The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case Series.

Nguyen MC, Shah MH, Liebner DA, Backes FJ, Phay J, Shirley LA

J Natl Compr Canc Netw 16


Inflammatory Myofibroblastic Tumor Driven by Novel NUMA1-ALK Fusion Responds to ALK Inhibition.

Rao N, Iwenofu H, Tang B, Woyach J, Liebner DA

J Natl Compr Canc Netw 16


Clinical Trials | Lead




Back to Find a Doctor Search

Make an Appointment


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Please enter a keyword (i.e. Name, Location) or choose a Cancer Type